Cencora, Inc. entered into a definitive agreement on March 21, 2026, to acquire EyeSouth Partners’ retina business for $1.1 billion, with affiliated retina physicians joining Retina Consultants of America upon closing. The transaction is expected to be slightly accretive to adjusted diluted EPS in the first twelve months post-closing, net of financing costs, and fiscal 2026 guidance is reaffirmed without assuming the close.
Key takeaways
Definitive agreement signed on March 21, 2026, to acquire EyeSouth Partners’ retina business for $1.1 billion
EyeSouth Partners’ affiliated retina physicians to join Cencora’s Retina Consultants of America (RCA)
Transaction subject to customary closing conditions, including regulatory approvals
Expected to be slightly accretive, net of financing costs, to adjusted diluted EPS in first 12 months after closing
Fiscal 2026 financial guidance reaffirmed, not contemplating transaction closing in fiscal 2026
Advisors include BofA Securities and Citi for Cencora, Jefferies LLC for EyeSouth Partners